lung cancer
Coverage of lung cancer in the Nexus archive.
- Rare transplant gives Stage 4 lung cancer patients a second chance at life — a Capitol Hill man is proof
David Peterson, a Stage 4 lung cancer patient, underwent a double lung transplant at Northwestern Medicine's DREAM program, the only U.S. hospital performing this treatment for such cases, after traditional therapies failed. The procedure, inspired by pandemic-era lung transplant techniques, saved his life.
- New robotic technology aids in early lung cancer detection
St. Peter's Health Partners is utilizing new robotic technology to enhance early detection of lung cancer. The tool aims to improve identification of the disease at an earlier stage.
- Dissident Hong Kong bookseller Lam Wing-kee dies aged 70
Lam Wing-kee, a Hong Kong bookseller who sold material critical of China, died at age 70 after battling lung cancer. His death marks the loss of a figure known for defying Chinese authorities through his bookstore activities.
- Aging Untold: The ‘Double-decker sandwich’ — when both sets of parents need care
The article discusses the 'double-decker sandwich' caregiving challenge where couples care for both sets of parents, along with heat risks for older adults, non-smoking lung cancer causes like radon, and a Vermont woman's global teddy bear initiative for traumatized children.
- Aging Untold: The ‘Double-decker sandwich’ — when both sets of parents need care
The article discusses the 'double-decker sandwich' caregiving challenge where couples care for both their parents and their in-laws, along with risks of heat waves for older adults, non-smoker lung cancer risks, and a teddy bear initiative for children in crisis. Experts provide strategies for managing caregiving duties and highlight health dangers and prevention methods.
- ‘I see hope’: how mindset shifts help Hong Kong cancer patients cope with diagnosis
The article discusses the psychological challenges faced by Hong Kong cancer patients and highlights support programs that are transforming treatment approaches. It features Sasa Hui Yuen-sim, a 67-year-old retiree diagnosed with breast cancer in June 2024 and lung cancer the following year, emphasizing the mental toll of her battle with multiple cancers.
- Gilead and Merck’s latest trial success and flop
GSK acquired Nuvalent, a biotech company with two drugs under FDA review for targeting genetic mutations in lung cancer, for $10.6 billion. Approval decisions for the drugs are expected later this year.
- GSK is acquiring lung cancer biotech Nuvalent in its biggest deal in over a decade
GSK is acquiring lung cancer biotech Nuvalent in its largest deal in over a decade. The all-cash transaction provides GSK with two late-stage lung cancer drugs under FDA review.
- GSK to buy US cancer treatment firm Nuvalent for $10.6bn
British drugmaker GSK, led by new CEO Luke Miels, has agreed to acquire US-based cancer treatment firm Nuvalent for $10.6 billion. The deal aims to strengthen GSK's oncology portfolio, with Nuvalent developing three late-stage lung cancer medications.
- GSK to buy US cancer treatment firm Nuvalent for $10.6bn
British drugmaker GSK has agreed to acquire US-based cancer treatment company Nuvalent for $10.6 billion to expand its oncology portfolio. The deal includes Nuvalent's three late-stage lung cancer medications.
- Swapping cigarettes for vapes does NOT significantly reduce the risk of lung cancer, study finds
A study found that switching from cigarettes to vapes does not significantly reduce the risk of lung cancer.
- Swapping cigarettes for vapes does NOT significantly reduce the risk of lung cancer, study finds
A study found that switching from cigarettes to vapes does not significantly reduce the risk of lung cancer. The research challenges the assumption that vaping is a safer alternative in terms of lung cancer prevention.
- Smoking is down, so why are more Hong Kong women getting lung cancer?
Lung cancer cases among Hong Kong women have increased by 20% over two decades despite lower smoking rates compared to men. Experts highlight genetic factors and call for citywide screenings to detect the disease earlier.
- WATCH: New lung cancer discovery may aid prevention
A new discovery related to lung cancer may help doctors predict and prevent the disease. ABC News' Dr. Tara Narula highlights this development as a potential aid in combating the world's deadliest cancer.
- Retired San Francisco firefighter dies from lung cancer after Blue Shield denies treatment claims
A retired San Francisco firefighter died from stage 4 lung cancer after Blue Shield denied his treatment claims. He spent his final months appealing to San Francisco's Health Service Board to intervene in the insurance dispute.
- Retired San Francisco firefighter dies from lung cancer after Blue Shield denies treatment claims
A retired San Francisco firefighter died from stage 4 lung cancer after Blue Shield denied approval for treatment. He spent his final months appealing to the City and County of San Francisco's Health Service Board to intervene.
- Cancer Drugmaker Parabilis Seeks $475 Million in US IPO
Cancer drugmaker Parabilis is seeking $475 million through a US IPO. The article references an MRI scan depicting lung cancer in the left pulmonary lobe.
- Retired San Francisco firefighter dies from lung cancer after Blue Shield denies treatment claims
A retired San Francisco firefighter died from stage 4 lung cancer after Blue Shield denied treatment claims. He appealed to the City and County of San Francisco's Health Service Board to intervene but was unsuccessful.
- Survivor, advocate: Inexpensive radon test can head-off lifelong lung cancer battle
Cary Hatch, a Stage 4 lung cancer survivor, advocates for inexpensive radon testing to prevent lung cancer. Radon, a radioactive gas, is the leading cause of lung cancer in non-smokers and second overall. She highlights affordable testing kits and mitigation systems to reduce exposure.
- Breakthrough pancreatic cancer treatment could double survival time
A new study on the pancreatic cancer drug daraxonrasib shows it could double survival rates for over 90% of patients. Researchers are investigating its potential effectiveness in lung, ovarian, and colorectal cancers.
- Chinese drug reduces lung cancer death risk by 34% in trial
A Chinese lung cancer drug reduced the risk of death by 34% in a late-stage trial, extending survival by four months when combined with chemotherapy for squamous non-small-cell lung cancer. The results highlight China's growing pharmaceutical innovation, alongside global advancements like Eli Lilly's obesity drug and a pancreatic cancer treatment.
- A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
An experimental lung cancer drug developed by Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial conducted in China, according to recently released data.
- How a Hong Kong app is a ‘vital lifeline’ for 76,000 patients navigating cancer care
A Hong Kong app serves as a vital lifeline for 76,000 cancer patients. Susan Tam, a 70-year-old diagnosed with lung cancer, faced severe skin rashes from her medication and tried various remedies without success.
- US adult cigarette smoking rate hits another all-time low
The U.S. adult cigarette smoking rate reached an all-time low of 9% in 2025, according to CDC survey data. The decline is attributed to higher taxes, smoking bans, and public health campaigns, though e-cigarette use remains steady at 7%. Advocates highlighted setbacks from Trump administration cuts to anti-smoking initiatives.
- STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
The article highlights positive data presented at the ASCO annual meeting for Bristol in multiple myeloma and Pfizer in lung cancer. STAT's coverage focuses on key developments from the event, emphasizing advancements in cancer treatments.
- GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
A new study found that GLP-1 weight-loss medications may slow the spread of several obesity-related cancers, including breast, prostate, lung, colorectal, and liver cancers.
- Daily briefing: Gene-activity ‘clock’ predicts biological ageing
A new gene-activity 'clock' tool predicts biological ageing in rodents and monkeys, and human time to death. The article also notes zebrafish sleep in stages similar to humans and highlights efforts to intercept lung cancer before it starts.
- Opinion: Sen. Dick Durbin: Trump is letting Big Tobacco target children
Sen. Dick Durbin shares his personal experience of losing his father to lung cancer and highlights his legislative efforts to reduce smoking, including a 1988 ban on smoking on domestic flights. He criticizes Trump for allowing Big Tobacco to target children.
- Could a pill prevent the world’s deadliest cancer?
A new 'interception' drug trial aims to prevent lung cancer before it develops, as reported in a 2026 Nature study. The research focuses on stopping the world's deadliest cancer through early intervention.
- Lung cancer in women emerges as a distinct disease
Lung cancer, previously predominantly affecting men, is now recognized as a distinct disease in women. The article highlights ongoing disparities in research, detection, and treatment for women with lung cancer.
- Global lung cancer burden shifting to middle-income countries
Lung cancer cases are rising fastest in middle-income countries like China due to high smoking rates and polluted air. Africa is projected to follow a similar trajectory, shifting the global lung cancer burden away from high-income nations.
- Science takes on the world’s most lethal malignancy
A study published in Nature on 27 May 2026 highlights that advancements in early detection, innovative drugs, and a deeper understanding of lung cancer are leading to better patient outcomes.
- Drugs that boost immunity are making lung cancer less deadly
Innovative drugs that boost immunity are extending life for lung cancer patients, and an experimental vaccine may potentially prevent the disease entirely. The study was published in Nature on May 27, 2026.
- Why Africa’s low rate of lung cancer is an illusion
The article highlights that Africa's reported low lung cancer rates are misleading due to inaccurate data collection, which misrepresents the health of people of African descent globally. Inaccurate data fails to capture true health trends, affecting both local and international populations.
- Five highlights from lung-cancer research
The article from Nature, published on May 27, 2026, highlights recent advancements in lung-cancer research, including treatment breakthroughs and improved screening methods. Key developments from studies are emphasized as significant progress in the field.
- AI and simple blood tests could catch lung cancer earlier
AI and simple blood tests may enable earlier detection of lung cancer, offering a potential solution to expand screening access in the United States where current methods are limited.
- Supermarket scans to spot your cancer: NHS scheme detects thousands more lung cancer cases early
The NHS has implemented a scheme using supermarket scans to detect thousands of lung cancer cases earlier. This initiative leverages consumer data to identify potential health risks and improve early diagnosis rates.
- Socially smoking in your twenties could leave you at risk of lung cancer decades later, research reveals
Research reveals that social smoking during one's twenties can significantly increase the risk of developing lung cancer decades later in life. The study highlights that even occasional smoking in young adulthood poses long-term health risks. This finding underscores the importance of avoiding smoking habits early on, regardless of frequency.
- GLP-1 drugs may reduce the risk of cancer progressing, study suggests
A new study suggests that GLP-1 drugs, commonly used for diabetes and weight loss, may help reduce the risk of cancer progression. The research indicates potential benefits of these medications beyond their primary therapeutic uses. Further investigation is needed to understand the mechanisms behind this protective effect.
- Barry Manilow, 82, seen for first time since 'losing his voice' amid lung cancer battle
Barry Manilow, 82, made a public appearance for the first time since reportedly losing his voice due to a battle with lung cancer. The singer's health struggles have been a focus of recent media attention.